Cargando…

High prevalence of insulin resistance among Brazilian chronic hepatitis C patients

OBJECTIVE: This study aims to estimate the prevalence of insulin resistance (IR) among chronic hepatitis C (CHC) patients and their related laboratory and demographic data. SUBJECTS AND METHODS: In this study, non-diabetic CHC patients referred to Viral Hepatitis Ambulatories from Rio de Janeiro (Br...

Descripción completa

Detalles Bibliográficos
Autores principales: Villar, Livia Melo, Caldas, Gabriela Cardoso, Scalioni, Leticia de Paula, Miguel, Juliana Custódio, da Silva, Elisangela Ferreira, Marques, Vanessa Alves, Villela-Nogueira, Cristiane Alves, Lewis-Ximenez, Lia Laura, Lampe, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522051/
https://www.ncbi.nlm.nih.gov/pubmed/29412389
http://dx.doi.org/10.1590/2359-3997000000315
_version_ 1785110274264530944
author Villar, Livia Melo
Caldas, Gabriela Cardoso
Scalioni, Leticia de Paula
Miguel, Juliana Custódio
da Silva, Elisangela Ferreira
Marques, Vanessa Alves
Villela-Nogueira, Cristiane Alves
Lewis-Ximenez, Lia Laura
Lampe, Elisabeth
author_facet Villar, Livia Melo
Caldas, Gabriela Cardoso
Scalioni, Leticia de Paula
Miguel, Juliana Custódio
da Silva, Elisangela Ferreira
Marques, Vanessa Alves
Villela-Nogueira, Cristiane Alves
Lewis-Ximenez, Lia Laura
Lampe, Elisabeth
author_sort Villar, Livia Melo
collection PubMed
description OBJECTIVE: This study aims to estimate the prevalence of insulin resistance (IR) among chronic hepatitis C (CHC) patients and their related laboratory and demographic data. SUBJECTS AND METHODS: In this study, non-diabetic CHC patients referred to Viral Hepatitis Ambulatories from Rio de Janeiro (Brazil) donated blood samples. Insulin was measured using a chemiluminescence immunoassay. IR was determined by HOMA-IR, where HOMA-IR > 2 was defined as IR. RESULTS: A total of 214 CHC patients were recruited (123 females aged 53.6 years ± 10.9 years). IR was present in 133 patients (62.1%) and was associated in bivariate analysis to higher mean values of age (p = 0.040), triglycerides (p = 0.032), glucose (p = 0.000), insulin (p = 0.000), waist circumference (p = 0.001), and body mass index (p = 0.007); however, none of these variables were significant in the multivariate analysis. CONCLUSIONS: The high prevalence of IR was observed among CHC patients, and there was no difference in clinical or laboratory parameters when both groups were compared in the multivariate analysis. This high IR prevalence could lead to a high risk for development of cardiovascular disease and metabolic disorders.
format Online
Article
Text
id pubmed-10522051
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Sociedade Brasileira de Endocrinologia e Metabologia
record_format MEDLINE/PubMed
spelling pubmed-105220512023-09-27 High prevalence of insulin resistance among Brazilian chronic hepatitis C patients Villar, Livia Melo Caldas, Gabriela Cardoso Scalioni, Leticia de Paula Miguel, Juliana Custódio da Silva, Elisangela Ferreira Marques, Vanessa Alves Villela-Nogueira, Cristiane Alves Lewis-Ximenez, Lia Laura Lampe, Elisabeth Arch Endocrinol Metab Brief Report OBJECTIVE: This study aims to estimate the prevalence of insulin resistance (IR) among chronic hepatitis C (CHC) patients and their related laboratory and demographic data. SUBJECTS AND METHODS: In this study, non-diabetic CHC patients referred to Viral Hepatitis Ambulatories from Rio de Janeiro (Brazil) donated blood samples. Insulin was measured using a chemiluminescence immunoassay. IR was determined by HOMA-IR, where HOMA-IR > 2 was defined as IR. RESULTS: A total of 214 CHC patients were recruited (123 females aged 53.6 years ± 10.9 years). IR was present in 133 patients (62.1%) and was associated in bivariate analysis to higher mean values of age (p = 0.040), triglycerides (p = 0.032), glucose (p = 0.000), insulin (p = 0.000), waist circumference (p = 0.001), and body mass index (p = 0.007); however, none of these variables were significant in the multivariate analysis. CONCLUSIONS: The high prevalence of IR was observed among CHC patients, and there was no difference in clinical or laboratory parameters when both groups were compared in the multivariate analysis. This high IR prevalence could lead to a high risk for development of cardiovascular disease and metabolic disorders. Sociedade Brasileira de Endocrinologia e Metabologia 2017-12-01 /pmc/articles/PMC10522051/ /pubmed/29412389 http://dx.doi.org/10.1590/2359-3997000000315 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Report
Villar, Livia Melo
Caldas, Gabriela Cardoso
Scalioni, Leticia de Paula
Miguel, Juliana Custódio
da Silva, Elisangela Ferreira
Marques, Vanessa Alves
Villela-Nogueira, Cristiane Alves
Lewis-Ximenez, Lia Laura
Lampe, Elisabeth
High prevalence of insulin resistance among Brazilian chronic hepatitis C patients
title High prevalence of insulin resistance among Brazilian chronic hepatitis C patients
title_full High prevalence of insulin resistance among Brazilian chronic hepatitis C patients
title_fullStr High prevalence of insulin resistance among Brazilian chronic hepatitis C patients
title_full_unstemmed High prevalence of insulin resistance among Brazilian chronic hepatitis C patients
title_short High prevalence of insulin resistance among Brazilian chronic hepatitis C patients
title_sort high prevalence of insulin resistance among brazilian chronic hepatitis c patients
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522051/
https://www.ncbi.nlm.nih.gov/pubmed/29412389
http://dx.doi.org/10.1590/2359-3997000000315
work_keys_str_mv AT villarliviamelo highprevalenceofinsulinresistanceamongbrazilianchronichepatitiscpatients
AT caldasgabrielacardoso highprevalenceofinsulinresistanceamongbrazilianchronichepatitiscpatients
AT scalionileticiadepaula highprevalenceofinsulinresistanceamongbrazilianchronichepatitiscpatients
AT migueljulianacustodio highprevalenceofinsulinresistanceamongbrazilianchronichepatitiscpatients
AT dasilvaelisangelaferreira highprevalenceofinsulinresistanceamongbrazilianchronichepatitiscpatients
AT marquesvanessaalves highprevalenceofinsulinresistanceamongbrazilianchronichepatitiscpatients
AT villelanogueiracristianealves highprevalenceofinsulinresistanceamongbrazilianchronichepatitiscpatients
AT lewisximenezlialaura highprevalenceofinsulinresistanceamongbrazilianchronichepatitiscpatients
AT lampeelisabeth highprevalenceofinsulinresistanceamongbrazilianchronichepatitiscpatients